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Abstract
Facility-based sentinel testing for COVID-19 was implemented in May 2020 to monitor the prevalence of COVID-19
amongst the Rohingya and host community in Cox’s Bazar, Bangladesh. In response both to low uptake of testing across
all camps, and rumours of an outbreak of an influenza-like illness in May/June 2020, the International Organization for
Migration (in partnership with ACAPS) undertook a qualitative study to collect accounts from the Rohingya relating
to testing and treatment, and to explore the possibility that what was thought to be an outbreak of influenza may have
been COVID-19. The report provided rich descriptions of the apprehension around testing and offered some clear
recommendations for addressing these. We developed a testing ‘script’ in response to these recommendations,
deploying it alongside a survey to determine reasons for declining a test. We compared testing uptake before deploying
the testing script, and after (controlling for the total number of consultations), to generate a crude measure of the
impact of the script on testing uptake. We coded reasons for declining a test thematically, disaggregated by status
(Rohingya and host community) and sex. Despite the small sample size our results suggest an increase in testing uptake
following the implementation of the script. Reasons provided by patients for declining a test included: 1) fear, 2)
the belief that COVID-19 does not exist, that Allah will prevent them from contracting it, or that their symptoms are not
caused by COVID-19, 3) no permission from husband/family, and 4) a preference to return at a later time for a test. Our
findings largely mirror the qualitative accounts in the International Organization for Migration/ACAPS report and suggest
that further testing amongst both populations will be complicated by fear, and a lack of clarity around testing. Our data
lend force to the recommendations in the International Organization for Migration/ACAPS report and emphasise that
contextual factors play a key role and must be considered in designing and implementing a health response to a novel
disease.
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Introduction
There are currently 860,494 Rohingya in Cox’s Bazar,
Bangladesh [1]. In addition, there are an estimated 335,
900 individuals in the host community [2]. Save the Chil-
dren International (SCI) currently operates one Primary
Health Care Centre (PHCC), eight health posts, and a
newly constructed Severe Acute Respiratory Infection Iso-
lation and Treatment Centre (SARI ITC) to serve both
Rohingya and host communities. In response to growing
concern about the potential for COVID-19 to cause signifi-
cant morbidity and mortality, WHO and the Bangladesh
Ministry of Health established eight sentinel testing sites
for COVID-19, including the SCI PHCC. The initial proto-
col (dated 24 May 2020) required that anyone presenting
at a sentinel site with any symptom of acute respiratory ill-
ness (ARI) be offered a COVID-19 test. Patients consenting
to a test would be asked to isolate at the sentinel site until
the test result was available (approximately 48 h). On 11
June 2020, in response to low testing uptake, the
Bangladesh Refugee Relief and Repatriation Commissioner
(RRRC) decided to allow patients to return home while
their test was being processed; however, uptake of testing
for COVID-19 at the PHCC (and across all sentinel sites)
remained low [3].
In response to low uptake of testing across all camps -
as well as reports of an outbreak of an influenza-like ill-
ness in the camps in May/June and the absence of a corre-
sponding increase in primary healthcare consultations -
the International Organization for Migration (IOM), in
partnership with ACAPS, undertook a qualitative study to
collect accounts from Rohingya around testing and treat-
ment, and to explore the possibility that what was thought
to be an outbreak of influenza may have been COVID-19.
The report, which was based on interviews collected by
Rohingya researchers between 25 May and 25 June 2020,
explored reasons for the low uptake of testing. The report
suggested that, “[a] general consensus seemed to have
formed in the community not to test and to avoid seeking
treatment” ([4], p. 2). The report further highlighted that
the Rohingya’s reasons for not engaging in testing were
many and included: rational concerns about being asked
to remain at a health facility for two days to await test re-
sults, lack of clarity about the testing process (including
why they were being asked to undergo testing), fear of
lockdown of entire sub-blocks as a result of a positive test,
concerns about incidents involving disclosure of patient
details and test results to the public, and a lack of clarity
on the benefits of testing [4].
Therefore, to increase testing uptake, and understand
testing acceptability, we created a script (Fig. 1) – ad-
dressing concerns raised in the IOM/ACAPS report - for
health care workers (HCW) to read to patients. In
addition, we asked HCWs to record some basic demo-
graphic information about patients who were offered a
test and, if they declined, to document the reason for re-
fusal. As the report cautioned against pressuring patients
for information, we designed the survey to be brief and
unintrusive.
Methods
The testing script was developed by the SCI Public
Health Director and the Monitoring, Evaluation, Ac-
countability and Learning (MEAL) Manager for the
Cox’s Bazar COVID-19 response. With the support of
the PHCC Medical Officer and the Laboratory Techni-
cian we trained PHCC staff on communicating the con-
tent of the testing script (both in Bangla and
Chittagonian) and on the collection of the survey data.
We deployed our testing script and survey using Kobo
Toolbox (Harvard Humanitarian Initiative, Cambridge,
MA). The survey was designed to collect age, status
(Rohingya or host community), and whether or not the
patient had agreed to a test. We also collected informa-
tion on the acceptability of testing by asking those who
Fig. 1 Standard COVID-19 testing script
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had declined a test to indicate their reason for refusal.
HCWs administered the test with support from a trans-
lator if required. No fields were mandatory, and staff
were requested not to put pressure on patients to ex-
plain their decision. We defined ‘uptake’ as the pro-
portion of tests administered compared to the
number of tests offered. We defined ‘acceptability’ as
the qualitative justification for declining a test. We
coded the reasons for declining a test thematically.
We used routinely collected data for total consulta-
tions, combined with testing data, to determine
change in uptake.
Results
We deployed the survey (see Table 1) between 9 July
and 21 October 2020. Of the 222 patients who were of-
fered a COVID-19 test 60% (n = 133) were women, 61%
were Rohingya (n = 136); just under half accepted the
offer of a test (n = 113, 51%). Of the 109 patients who
refused a test, 26 (24%) declined to provide a reason for
doing so. The four most commonly cited reasons (com-
prising 88% of the responses) were: 1) fear (n = 27; n =
21 female; n = 23 Rohingya), 2) does not believe in
COVID-19, believes Allah will protect them from con-
tracting COVID-19, or does not believe symptoms are
due to COVID-19 (n = 25; n = 17 female, n = 18
Rohingya), 3) no permission from husband/family (n =
11; n = 11 female, n = 11 Rohingya), and patient will
come back later (n = 10; n = 4 female, n = 4 Rohingya).
Univariate analysis was performed using the chi-
square test of independence to assess the hypothesis
of association between the observed frequencies in
the categorical variables of script use and test consent
status in new consultations (see Fig. 2). We consid-
ered a p-value of < 0.05 as statistically significant. The
association between script use and test consent status
was statistically significant, X2 (1, N = 6180) = 49.2
p = < 0.001 with patients offered a testing script more
likely to consent to COVID-19 testing.
Discussion
Our survey demonstrates that though our efforts to pro-
vide clarity and the necessary assurances around testing
have significantly improved uptake, only half of eligible
patients were willing to accept the offer of a COVID-19
test. Many patients declined to provide a justification for
refusing a test; however, the justifications that were pro-
vided suggest: fear, poor understanding of COVID-19
susceptibility and symptoms, lack of an urgency around
testing, lack of understanding of the benefits of testing
(or low appeal of the benefits when compared to the
risks), and an inability to consent to a test without per-
mission from a family member (most often a husband).
It is worth noting that responses indicating that patients
did not believe they had COVID-19, or did not believe
that their symptoms were indicative of COVID-19, may
reflect the assumption that the outbreak had happened
earlier in the year as suggested by the IOM/ACAPS re-
port [4]. We also demonstrate that addressing Rohingya
concerns by explaining the purpose of test improved
uptake.
A key limitation to our study is its small sample size
which may have increased the probability of Type 2
error. Furthermore, we accept that a range of responses
(e.g. having already had a test, needing permission from
husband/family, or promises to return later for a test)
may proxy for fear or disinterest. However, the re-
sponses to our survey, regardless of their relative propor-
tion and lack of statistical power, are notable in that
they lend force to the findings of the qualitative accounts
detailed in the IOM/ACAPS report which found that the
Rohingya population went to great lengths to avoid be-
ing tested owing to historical fears of mistreatment by
authorities and health actors, to more recent accounts of
“…negative, stigmatising, undignified, and difficult expe-
riences around the testing and treatment process” [4, 5].
Finally, we have demonstrated that uptake of testing in-
creased once we began providing standard, scripted as-
surances around the confidentiality of test results, and
Table 1 Demographic characteristics and results
Age
Mean (SD) 31 (14.58)
Median 27
Range 14–100
Sex
Female 133 60%
Male 89 40%
Status
Rohingya 136 61%
Host community 86 39%
Agreed to test
Yes 113 51%
No 109 49%
Reason (n = 83)
Fear 27 33%
Does not believe in COVID-19; believes Allah
will protect her/him from COVID-19; does
not believe s/he has symptoms of COVID-19
25 30%
Husband/family will not allow; does not
have permission
11 13%
Will come back later 10 12%
Other (e.g. has already had test…) 10 12%
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information addressing some of the lack of clarity
around the testing protocol.
Conclusion
The IOM/ACAPS report cautions that, “[a] general con-
sensus seems to have formed in the community not to
test” and that “applying more pressure or trying to ‘in-
vestigate’ events may frighten people, resulting in their
hiding or fleeing from such efforts” ([4], p. 2). Further-
more, various breaches of confidentiality early in the re-
sponse have compounded mistrust around testing [4].
Further testing within this population to evidence the
trajectory of the outbreak, and to establish if accounts of
a rise in ARIs in the camps in May–June may have been
COVID-19, would likely require a large-scale sero-
survey. However, our survey suggests that challenges to
testing are likely to persist unless considerable efforts
are made to address rational fears around testing relating
largely to the complex history of the Rohingya popula-
tion, and to more proximal and immediate fears of lock-
down or disclosure of test results. High vaccine uptake
in the camps suggests that Rohingya/host populations
may not be averse to sero-surveys provided their bene-
fits are clearly communicated. Our experience of low
uptake of COVID-19 testing amongst PHCC patients
in Camp 21 underlines the importance of considering
contextual factors when designing and implementing a
health response, especially to a novel disease.
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